Emerging Trends in Rare Disease Trials: Orphan Drugs, Genetics & Patient Voices
Rare disease trials in 2024-2025 are reshaped by genetic therapies, refined orphan drug policies, and empowered patient voices, offering new hope and access pathways for ultra-rare conditions.
Robert Maxwell
Aug 13, 2025
orphan drug access
ultra-rare genetic diseases
rare disease support
gene therapy research